The mTOR kinase inhibitor everolimus synergistically enhances the anti‐tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS‐123 on Mantle cell lymphoma

Jiao Li(Harvard University), Jun Zhu(Peking University)
International Journal of Cancer
September 14, 2017
Cited by 29


Related Papers